文献速递眼底病与葡萄膜炎

印度尼西亚糖尿病视网膜病变的估计医疗保健成本及其2025年预测

The estimated healthcare cost of diabetic retinopathy in Indonesia and its projection for 2025.
PubMed 文献 · Br J Ophthalmol · 2019-07-08

PURPOSE: To estimate the total healthcare cost associated with diabetic retinopathy (DR) in type 2 diabetes in Indonesia and its projection for 2025. METHODS: A prevalence-based cost-of-illness model was constructed from previous population-based DR study.…

核心结论

  • 2017年印度尼西亚DR估计医疗成本相当高,接近2017年国家预算的2%,预测2025年将显著增加至超过三倍。
  • 需激光联合玻璃体腔注射治疗的DR可能产生最高成本。
  • 因此,延迟或预防重度DR的公共卫生干预可能大幅降低印度尼西亚DR的医疗成本。

研究设计与样本

  • 基于患病率的成本-of-疾病模型,数据来源于既往基于人群的DR研究。
  • 2025年预测基于2025年估计糖尿病人口。
  • DR直接治疗成本从医疗保健角度估计;患者角度成本通过详细访谈获得,仅包括交通费用和与治疗相关的误工天数。
  • 根据DR严重程度建立四种成本-of-疾病模型:无需必要治疗的DR、需激光治疗、激光+玻璃体腔注射、激光+玻璃体腔注射+玻璃体切除术。
  • 所有成本以2017年美元估计。

临床怎么用

  • 原文结论指出,延迟或预防重度DR的公共卫生干预可能大幅降低印度尼西亚DR的医疗成本。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To estimate the total healthcare cost associated with diabetic retinopathy (DR) in type 2 diabetes in Indonesia and its projection for 2025. METHODS: A prevalence-based cost-of-illness model was constructed from previous population-based DR study. Projection for 2025 was derived from estimated diabetes population in 2025. Direct treatment costs of DR were estimated from the perspective of healthcare. Patient perspective costs were obtained from thorough interview including only transportation cost and lost of working days related to treatment. We developed four cost-of-illness models according to DR severity level, DR without necessary treatment, needing laser treatment, laser +intravitreal (IVT) injection and laser + IVT +vitrectomy. All costs were estimated in 2017 US$. RESULTS: The healthcare costs of DR in Indonesia were estimated to be $2.4 billion in 2017 and $8.9 billion in 2025. The total cost in 2017 consisted of the cost for no DR and mild-moderate non-proliferative DR (NPDR) requiring eye screening ($25.9 million), severe NPDR or proliferative DR (PDR) requiring laser treatment ($0.25 billion), severe NPDR or PDR requiring both laser and IVT injection ($1.75 billion) and advance level of PDR requiring vitrectomy ($0.44 billion). CONCLUSIONS: The estimated healthcare cost of DR in Indonesia in 2017 was considerably high, nearly 2% of the 2017 national state budget, and projected to increase significantly to more than threefold in 2025. The highest cost may incur for DR requiring both laser and IVT injection. Therefore, public health intervention to delay or prevent severe DR may substantially reduce the healthcare cost of DR in Indonesia.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Sasongko MB, Wardhana FS, Febryanto GA, et al. The estimated healthcare cost of diabetic retinopathy in Indonesia and its projection for 2025. Br J Ophthalmol. 2019. PMID: 31285276. doi:10.1136/bjophthalmol-2019-313997

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。